After weathering a brutal economy in 2009 and a wave of layoffs in 2010 and 2011, it appeared that the drug industry, from a jobs perspective, was headed towards a promising 2012. Yet recent events—AstraZeneca announcing it will terminate some 7,300 employees worldwide, for example—have dented optimism. When asked what made him happiest about his job, one AZ employee who answered our survey this year lamented, “Nothing. I’m now redundant after 25 years of service.”
Click sobre imagen para ampliar.The most sweeping shift in our data is from an emphasis on external economic concerns to internal cost-cutting, restructurings, and other internal matters
Chart shows that roughly 50% of you have taken on an increased workload due to staff cuts. If there’s a silver lining, it’s that this percentage was 10% higher last year.
The statistics in Figures 6 and 7 roughly correspond to what you told us in 2011—burnout continues to be a significant issue, for you individually, but also for your colleagues and site productivity.
Entradas
No hay comentarios:
Publicar un comentario